Commentary Open Access
Volume 1 | Issue 3 | DOI: https://doi.org/10.33696/Neurol.1.011
Treatment of Neurological Manifestations of Mucopolysaccharidoses: Translational Considerations in Drug Development
Anita Grover1,*, Charles A O’Neill2, Simon A. Jones1
- 2BioMarin Pharmaceutical, Inc; Novato, CA, USA
- 1University of Manchester; Manchester, United Kingdom
Corresponding Author
Anita Grover, anitagrv@gmail.com
Received Date: May 01, 2020
Accepted Date: June 06, 2020
Grover A, O’Neill CA, Jones SA. Treatment of Neurological Manifestations of Mucopolysaccharidoses: Translational Considerations in Drug Development. J Exp Neurol. 2020;1(2): 55-61.
Copyright: © 2020 Grover A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Prevention of Suicide in Persons with Progressive Neurological Diseases
People suffering with neurological diseases are at risk of committing suicide. A case-control study found increased risk of attempted suicide in patients with nine chronic neurological diseases [1]
Treatment of Neurological Manifestations of Mucopolysaccharidoses: Translational Considerations in Drug Development
Since the development of Ceredase® and Cerezyme® for the treatment of Gaucher disease in the early 1990s, treatment of lysosomal storage disorders via enzyme replacement therapy (ERT) has provided life-changing benefit to patients and their families.
Can ECT Improve the Motor Symptoms of a Neurological Disease? A Case of Dopa-Responsive Dystonia
Electroconvulsive therapy (ECT) is a well-known treatment for mood disorders. There have also been reports of improvement in neurological disorders following ECT, particularly in Parkinson’s disease, but also in some cases of cervical dystonia, orofacial dystonia, or blepharospasm.
A Rodent Lumbosacral Spinal Cord Injury Model Reflecting Neurological and Urological Deficits of Humans
Spinal cord injury (SCI) to the terminal segments of the spinal cord causes severe disruption of the neural circuitry of the bladder, resulting in neurogenic underactive bladder (nUAB). We developed a rodent lumbosacral injury model to investigate the effects of bladder function and structure.
COVID-19, the Immune System, and Neurological Damage
The Germ Theory of Disease was solidified in the 19th century by Louise Pasteur and Robert Koch. They systematically visualized, isolated, and quantified microscopic pathogens as causative agents of diseases and epidemics. Viruses are submicroscopic; therefore, they were discovered later as pathogens by indirect methods [1,2].